HeartSciences (HSCS) CEO Andrew Simpson Big Biz Show Interview – No Current Frontline Medical Device for Heart Disease Screening

"Skip to content\nHome\nProducts\nClinical\nNews\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences (HSCS) CEO Andrew Simpson Big Biz Show Interview – No Current Frontline Medical Device for Heart Disease Screening\nMay 4, 2023\n\nEvery 40 seconds, someone dies of heart disease. Millions of people go undiagnosed because a valve issue, enlarged heart or coronary arterial disease often doesn’t affect heart rhythm until an acute stage. Learn why an AI-enabled ECG might help in the future.\n\nSee full Tweet at the following link: HeartSciences $HSCS #AI #ECG on Twitter: “Every 40 seconds, someone dies of heart disease. Millions of people go undiagnosed because a valve issue, enlarged heart or coronary arterial disease often doesn’t affect heart rhythm until an acute stage. Learn why an AI-enabled ECG might help in the future. $HSCS #AI #ECG https://t.co/TF5xgp0gGL” / Twitter\n\nContacts\nMEDIA RELATIONS\n\nGene Gephart\nDirector of Marketing\n+1-682-244-2578 (US)\n\ngene.gephart@heartsciences.com\nINVESTOR CONTACT\n\nMark Komonoski – Partner\nIntegrous Communications\nDirect: 877-255-8483\n\ninvestorrelations@heartsciences.com\nwww.integcom.us\n